Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 173,912 | 162,054 | 151,668 | 118,697 | 102,660 |
| Cost of Goods | 12,113 | 9,396 | 10,927 | 8,309 | 6,237 |
| Gross Profit | 161,799 | 152,658 | 140,741 | 110,388 | 96,423 |
| Operating Expenses | 181,820 | 159,176 | 149,644 | 125,226 | 118,844 |
| Operating Income | -19,908 | -6,122 | -7,976 | -14,529 | -22,184 |
| Interest Expense | 2,156 | 2,128 | 2,214 | 2,268 | 2,240 |
| Other Income | 6,229 | 3,635 | 3,876 | 4,212 | 4,084 |
| Pre-tax Income | -15,835 | -4,615 | -6,314 | -12,585 | -20,340 |
| Income Tax | 2,716 | 2,352 | N/A | N/A | N/A |
| Net Income Continuous | -18,551 | -6,967 | -8,373 | -12,585 | -20,340 |
| Net Income | $-18,551 | $-6,967 | $-8,373 | $-12,585 | $-20,340 |
| EPS Basic Total Ops | -0.43 | -0.16 | -0.17 | -0.30 | -0.48 |
| EPS Basic Continuous Ops | -0.43 | -0.16 | -0.18 | -0.30 | -0.48 |
| EPS Diluted Total Ops | -0.43 | -0.16 | -0.17 | -0.30 | -0.48 |
| EPS Diluted Continuous Ops | -0.43 | -0.16 | -0.18 | -0.30 | -0.48 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.16 | -0.20 | -0.30 | -0.48 |
| EBITDA(a) | $-19,504 | $-6,375 | $-8,302 | $-15,451 | $-23,294 |